{ "instance": { "utrs-20221231.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 39 }, "contextCount": 3, "dts": { "calculationLink": { "local": [ "utrs-20221231_cal.xml" ] }, "definitionLink": { "local": [ "utrs-20221231_def.xml" ] }, "inline": { "local": [ "utrs-20221231.htm" ] }, "labelLink": { "local": [ "utrs-20221231_lab.xml" ] }, "presentationLink": { "local": [ "utrs-20221231_pre.xml" ] }, "schema": { "local": [ "utrs-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 690, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 39, "memberCustom": 0, "memberStandard": 0, "nsprefix": "utrs", "nsuri": "http://minervasurgical.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "utrs-20221231.htm", "contextRef": "C_0e2de687-6f42-45aa-a709-0b8cfd88f935", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "utrs-20221231.htm", "contextRef": "C_0e2de687-6f42-45aa-a709-0b8cfd88f935", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "Icfr Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Board of Directors" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum", "verboseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "California" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201901Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update 2019-01 [Member]", "terseLabel": "ASC 842" } } }, "localname": "AccountingStandardsUpdate201901Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "totalLabel": "Accounts Payable, Current, Total" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net", "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfContractBalanceDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails": { "order": 3.0, "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Bonuses, Current", "terseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedVacationCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails": { "order": 2.0, "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Vacation, Current", "terseLabel": "Accrued vacation" } } }, "localname": "AccruedVacationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation and amortization", "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "periodEndLabel": "Additional Paid in Capital, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Beginning Balance", "terseLabel": "Additional paid-in capital", "totalLabel": "Additional Paid in Capital, Total" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation expense", "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Advertising Expense", "terseLabel": "Advertising expenses" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense", "verboseLabel": "Compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt premium and discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense on intangible assets", "totalLabel": "Amortization of Intangible Assets, Total" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Area of Real Estate Property", "terseLabel": "Area of lease facility" } } }, "localname": "AreaOfRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "totalLabel": "Total financial assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration liability", "totalLabel": "Business Combination, Contingent Consideration, Liability, Total" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Contingent consideration liability, current" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration liability, net of current portion" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combination" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Formation and Business of the Company" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompany" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails": { "order": 0.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash", "periodEndLabel": "Cash, Ending Balance", "periodStartLabel": "Cash, Beginning Balance", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "terseLabel": "Cash and cash equivalents", "totalLabel": "Total cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]", "terseLabel": "Cash equivalents:" } } }, "localname": "CashAndCashEquivalentsAtCarryingValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashEquivalentsAtCarryingValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value [Abstract]", "terseLabel": "Cash equivalents:" } } }, "localname": "CashEquivalentsAtCarryingValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]", "terseLabel": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date", "terseLabel": "Change in Accounting Principle, Accounting Standards Update, Adoption Date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price", "verboseLabel": "Exercise Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Number of shares of common stock issuable", "verboseLabel": "Number of Shares of Common Stock Issuable" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommissionsExpensePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commissions Expense, Policy [Policy Text Block]", "terseLabel": "Contract Costs" } } }, "localname": "CommissionsExpensePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 8)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies and Litigation" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Common stock available for future grants", "verboseLabel": "Common stock, shares reserved for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, Issued", "totalLabel": "Common Stock, Shares, Issued, Total" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "terseLabel": "Common stock, $0.001 par value, 100,000,000 shares authorized, and 29,816,161 shares and 28,822,283 shares issued and outstanding as of December 31, 2022 and 2021, respectively", "totalLabel": "Common Stock, Value, Issued, Total" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plan" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlan" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liability:" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Construction in Progress [Member]", "terseLabel": "Construction in Progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]" } } }, "localname": "ContractWithCustomerAssetAndLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of Contract Balance" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability", "terseLabel": "Contract liabilities", "totalLabel": "Contract with Customer, Liability, Total", "verboseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liability\u2014current", "verboseLabel": "Contract liability-current (see Note 6)" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfContractBalanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized included in contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debt [Member]", "terseLabel": "Convertible Note", "verboseLabel": "Convertible Promissory Notes" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable convertible preferred stock converted", "terseLabel": "Redeemable convertible preferred stock converted", "verboseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold", "totalLabel": "Cost of Goods and Services Sold, Total" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Income tax expense", "totalLabel": "Current Income Tax Expense (Benefit), Total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Conversion of 2018, 2019 and 2020 Notes into common stock upon initial public offering", "verboseLabel": "Aggregate outstanding principal and accrued interest of convertible promissory notes" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom1", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Conversion of preferred stock" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails": { "order": 0.0, "parentTag": "utrs_TermLoanIncludingAccruedInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "terseLabel": "Debt financing", "totalLabel": "Total", "verboseLabel": "Principal" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price per share" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Terms of Conversion Feature", "terseLabel": "Debt instrument, convertible, terms of conversion feature" } } }, "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Decrease, Forgiveness", "terseLabel": "Debt instrument forgiveness" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Amount borrowed" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Estimated fair value of aggregate outstanding derivative instrument", "totalLabel": "Debt Instrument, Fair Value Disclosure, Total" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Fee Amount", "terseLabel": "Debt instrument fees" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt instrument effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate Terms", "terseLabel": "Debt instrument, interest rate terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Payment Terms", "terseLabel": "Debt instrument payment terms" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment", "terseLabel": "Debt instrument, periodic payment", "totalLabel": "Debt Instrument, Periodic Payment, Total" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails": { "order": 1.0, "parentTag": "utrs_TermLoanIncludingAccruedInterest", "weight": -1.0 }, "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": 1.0, "parentTag": "utrs_TermLoanIncludingAccruedInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedLabel": "Less: unamortized debt discounts and issuance costs", "negatedTerseLabel": "Less: Debt discount and debt issuance cost", "terseLabel": "Less: net of unamortized debt premium (discounts) and issuance costs", "totalLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedPremium": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Premium", "terseLabel": "Unamortized premium", "totalLabel": "Debt Instrument, Unamortized Premium, Total" } } }, "localname": "DebtInstrumentUnamortizedPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Debt Discount" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Related Commitment Fees and Debt Issuance Costs", "terseLabel": "Interest expense related to accretion of debt discount , debt issuance costs and exit fees", "verboseLabel": "Interest expense related to accretion of debt discount, debt issuance costs" } } }, "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Offering Costs", "terseLabel": "Deferred offering costs other than underwriting discounts and commissions", "verboseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest expense limitation carryforward" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "Research and development credits" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "totalLabel": "Total" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards", "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Accruals and reserves", "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: valuation allowance", "terseLabel": "Less: valuation allowance", "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedLabel": "Lease liability" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Deposits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deposits", "totalLabel": "Deposits, Total" } } }, "localname": "Deposits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense on property and equipment", "totalLabel": "Depreciation, Depletion and Amortization, Total" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Derivative liability, fair value", "totalLabel": "Derivative Liability, Fair Value, Gross Liability, Total" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Financial Instruments, Liabilities [Member]", "terseLabel": "Derivative Liabilities" } } }, "localname": "DerivativeFinancialInstrumentsLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derivative Liability", "terseLabel": "Derivative liabilities", "totalLabel": "Derivative Liability, Total" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Developed Technology", "terseLabel": "Developed Technology Rights", "verboseLabel": "Developed Technology [Member]" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation Of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation Of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "terseLabel": "Federal" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income (loss) per share attributable to common stockholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share attributable to common stockholders, basic", "totalLabel": "Earnings Per Share, Basic, Total" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share attributable to common stockholders, diluted", "totalLabel": "Earnings Per Share, Diluted, Total" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Share Attributable to Common Stockholders" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share Attributable to Common Stockholders" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholders2" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 0.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Federal statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent", "terseLabel": "Other permanent items" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "terseLabel": "Stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State blended rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation", "totalLabel": "Total accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense", "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Compensation expense not yet recognized, period for recognition", "verboseLabel": "Unrecognized stock-based compensation expense, weighted-average recognition period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Stock [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Options to Purchase Common Stock" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Related party transaction ownership percentage", "verboseLabel": "Ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value By Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Change in Fair Value of the Redeemable Convertible Preferred Stock Warrant Liability, Derivative Liabilities and Contingent Consideration Liability" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]", "terseLabel": "Fair value measurements" } } }, "localname": "FairValueMeasurementInputsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in fair value", "totalLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending fair value", "periodStartLabel": "Beginning fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Financial Liabilities Fair Value Disclosure", "totalLabel": "Total financial liabilities" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableImpairedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Receivable, Impaired [Line Items]", "terseLabel": "Financing Receivable Impaired [Line Items]" } } }, "localname": "FinancingReceivableImpairedLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Useful lives of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": 5.0, "parentTag": "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": 1.0, "parentTag": "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": 4.0, "parentTag": "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": 6.0, "parentTag": "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": 3.0, "parentTag": "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": 2.0, "parentTag": "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails": { "order": 0.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Value", "totalLabel": "Finite-Lived Intangible Assets, Gross, Total" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance", "terseLabel": "Intangible asset, net", "totalLabel": "Net Carrying Value", "verboseLabel": "Net Carrying Value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Weighted average amortization period for intangible assets", "verboseLabel": "Remaining life (years)" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and Fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain (loss) on extinguishment of debt", "negatedLabel": "Loss on extinguishment of convertible notes", "terseLabel": "Loss on extinguishment of convertible notes", "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total", "verboseLabel": "Gain on forgiveness of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "General and Administrative Expense, Total" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General and Administrative Expense [Member]", "terseLabel": "General and Administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]", "terseLabel": "Product Warranties" } } }, "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IPO [Member]", "terseLabel": "Initial Public Offering" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairment of long-lived assets", "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]", "terseLabel": "Numerator" } } }, "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense", "negatedTerseLabel": "Income tax benefit", "terseLabel": "Income tax (benefit) provision", "totalLabel": "Total income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Valuation allowance increased" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest Expense", "negatedLabel": "Interest expense (includes $nil and $4.5 million to related parties in years ended December 31, 2022 and 2021, respectively)", "terseLabel": "Interest expense", "totalLabel": "Interest Expense, Total" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "terseLabel": "Interest expense on debt", "totalLabel": "Interest Expense, Debt, Total" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest Expense, Related Party", "terseLabel": "Interest expense, related party" } } }, "localname": "InterestExpenseRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperationsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Interest Payable, Current", "terseLabel": "Accrued interest expense" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Interest Payable", "negatedLabel": "Less: Interest", "terseLabel": "Accrued interest expense" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfInventoryDetails": { "order": 0.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Total inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfInventoryDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Inventory Write-down", "terseLabel": "Provision for excess or obsolete inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Investment Income, Interest", "terseLabel": "Interest income", "totalLabel": "Investment Income, Interest, Total" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Lease Cost" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of Lease Costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Maturities and Future Minimum Rental Obligation Required under New Non-cancellable Lease" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total undiscounted lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalObligationRequiredUnderNewNoncancellableLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails2": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liability:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure", "terseLabel": "Fair value of warrants", "totalLabel": "Liabilities, Fair Value Disclosure, Total" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoanRestructuringModificationNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan Restructuring Modification Name [Axis]", "terseLabel": "Loan Restructuring Modification Name" } } }, "localname": "LoanRestructuringModificationNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LoanRestructuringModificationNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan Restructuring Modification Name [Domain]", "terseLabel": "Loan Restructuring Modification Name" } } }, "localname": "LoanRestructuringModificationNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long-Term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt", "totalLabel": "Long-term Debt, Current Maturities, Total" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "totalLabel": "Long-term Debt, Excluding Current Maturities, Total" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate", "terseLabel": "Accrue interest fixed rate" } } }, "localname": "LongTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDamagesPaidValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss Contingency, Damages Paid, Value", "terseLabel": "Loss contingency damages and interest paid" } } }, "localname": "LossContingencyDamagesPaidValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 }, "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 0.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Money Market Funds, at Carrying Value", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfCashAndCashEquivalentsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net loss attributable to common stockholders", "negatedLabel": "Net Loss", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net Income (Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Operating Segments", "terseLabel": "Number of operating segment" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segment" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OpenTaxYear": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Open Tax Year", "terseLabel": "Open tax year" } } }, "localname": "OpenTaxYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails": { "order": 0.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "terseLabel": "Operating lease liabilities", "totalLabel": "Total operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails2": { "order": 0.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "terseLabel": "Operating lease liability", "verboseLabel": "Less: current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails2": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liability, net of current maturities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows used for lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use asset", "verboseLabel": "Right of use asset acquired under operating lease on the adoption of ASC 842" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average incremental borrowing rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 0.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months", "terseLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesRentExpenseNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Leases, Rent Expense, Net", "terseLabel": "Rent expense", "totalLabel": "Operating Leases, Rent Expense, Net, Total" } } }, "localname": "OperatingLeasesRentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carry forwards", "totalLabel": "Operating Loss Carryforwards, Total" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Accrued Liabilities, Current", "terseLabel": "Others" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails": { "order": 1.0, "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Employee-related Liabilities, Current", "terseLabel": "Other accrued personnel related expenses" } } }, "localname": "OtherEmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Intangible Assets [Member]", "terseLabel": "Other Intangible Assets" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Operating Income (Expense), Net", "terseLabel": "Other expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentInKindPIKNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payment in Kind (PIK) Note [Member]", "terseLabel": "Payment in Kind (PIK) Note" } } }, "localname": "PaymentInKindPIKNoteMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfLoanCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments of Loan Costs", "terseLabel": "Payments of loan costs" } } }, "localname": "PaymentsOfLoanCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments of Stock Issuance Costs", "terseLabel": "Net of issuance costs and underwriting discount" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleSharesIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Convertible, Shares Issuable", "terseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion" } } }, "localname": "PreferredStockConvertibleSharesIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares, Issued", "totalLabel": "Preferred Stock, Shares Issued, Total" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred stock, shares, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "terseLabel": "Preferred stock, $0.001 par value, 5,000,000 shares authorized, and no shares issued and outstanding as of December 31, 2022 and 2021", "totalLabel": "Preferred Stock, Value, Issued, Total" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 0.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses", "totalLabel": "Prepaid Expense, Current, Total" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrincipalForgivenessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Principal Forgiveness [Member]", "terseLabel": "Principal Forgiveness" } } }, "localname": "PrincipalForgivenessMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "terseLabel": "Private placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Convertible Debt", "terseLabel": "Gross proceeds from offering", "verboseLabel": "Aggregate cash proceeds" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net proceeds after deducting underwriting discounts and commissions", "terseLabel": "Proceeds from initial public offering, net of underwriting discount and commission", "verboseLabel": "Net proceeds from initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from long term debt", "totalLabel": "Proceeds from Issuance of Long-term Debt, Total" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfSecuredDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from (Repayments of) Secured Debt", "terseLabel": "Proceeds from repayments of debt" } } }, "localname": "ProceedsFromRepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Costs to perform warranty obligations", "terseLabel": "Product warranty cost" } } }, "localname": "ProductWarrantyExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Property and equipment, useful life, description" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails": { "order": 0.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "terseLabel": "Property and equipment, gross", "totalLabel": "Property, Plant and Equipment, Gross, Total" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property and equipment, useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for bad debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Redeemable Convertible Preferred Stock" } } }, "localname": "RedeemableConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related party transaction amounts" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Repayments of Secured Debt", "terseLabel": "Repayments of debt" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Research and Development Expense", "terseLabel": "Research and development", "totalLabel": "Research and Development Expense, Total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development Expense [Member]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Restricted Cash", "terseLabel": "Restricted cash", "totalLabel": "Restricted Cash, Total" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Restricted Cash, Current", "terseLabel": "Restricted cash, current" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash, net of current portion" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSU", "verboseLabel": "Restricted Stock Units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Accumulated deficit", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "terseLabel": "Accumulated deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues", "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Aggregate number of shares agreed to be sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sale of Stock, Price Per Share", "terseLabel": "Purchase price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Anti-dilutive Securities Outstanding in Common Stock Equivalent Excluded from Computation of Diluted Weighted Average Shares Outstanding" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Tax Effects of Temporary Differences and Carryforwards of Deferred Tax Deferred Tax and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary of Reconciliation Between Federal Statutory Rate and Effective Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Summary of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangible Assets, Net" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfImpairedFinancingReceivableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Impaired Financing Receivable [Table]", "terseLabel": "Schedule Of Impaired Financing Receivable [Table]" } } }, "localname": "ScheduleOfImpairedFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Contractual Maturities of Financing Obligations" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Fair Value of Stock Options Estimated Using Weighted-Average Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of Common Stock Warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Subsidiary or Equity Method Investee [Table]" } } }, "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Changes in Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]", "terseLabel": "Schedule of Restricted Stock Units" } } }, "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Future Amortization Expense of Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segments" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing", "totalLabel": "Selling and Marketing Expense, Total" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and Marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of Shares Underlying Outstanding Restricted Stock, Forfeited or cancelled", "terseLabel": "Number of Shares Underlying Outstanding Restricted Stock, Forfeited or cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Unvested, Forfeited or Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of Shares Underlying Outstanding Restricted Stock, Granted", "verboseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Unvested, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of Shares Underlying Outstanding Restricted Stock, Unvested, Ending Balance", "periodStartLabel": "Number of Shares Underlying Outstanding Restricted Stock, Unvested, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value, Unvested, Ending Balance", "periodStartLabel": "Weighted Average Grant Date Fair Value, Unvested, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected dividends", "terseLabel": "Dividend yield", "verboseLabel": "Dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility", "verboseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected volatility maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected volatility minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Number of Shares Underlying Outstanding Options, Shares Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Shares exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Aggregate intrinsic value of common stock exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Number of Shares Underlying Outstanding Options, Forfeited or Cancelled", "terseLabel": "Number of Shares Underlying Outstanding Options, Forfeited or Cancelled", "totalLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options forfeited or cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Number of Shares Underlying Outstanding Options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of Shares Underlying Outstanding Options, Ending balance", "periodStartLabel": "Number of Shares Underlying Outstanding Options, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Oustanding ending balance", "periodStartLabel": "Weighted Average Exercise Price, Outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Number of Shares Underlying Outstanding Options, Vested and Expected to Vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Shares purchased by participants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award", "terseLabel": "Purchase shares of common stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options exercised", "verboseLabel": "Aggregate exercise price of exercised shares" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche One [Member]", "terseLabel": "Tranche One" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "terseLabel": "Tranche Two" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage of vesting rights" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term", "verboseLabel": "Expected warrant life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Term (in years), Shares exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Term (in years), Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Term (in years), Vested and Expected to Vest" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Fair value of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Purchase price of common stock, percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued offering price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "terseLabel": "State" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Number of common stock issued upon conversion", "verboseLabel": "Conversion of Series D redeemable convertible preferred stock into common stock upon initial public offering, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "ESPP purchase, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of shares sold and issued", "verboseLabel": "Issuance of common stock upon initial public offering, net of issuance costs and underwriting discount of $8,414, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Issuance of common stock upon release of RSUs, shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Number of Shares Underlying Outstanding Options, Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of Series D redeemable convertible preferred stock into common stock upon initial public offering" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock upon initial public offering, net of issuance costs and underwriting discount of $8,414" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Issuance of common stock upon release of RSUs" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Shares", "terseLabel": "Shares subject to repurchase" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders` equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquity2" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]", "terseLabel": "Redeemable Convertible Preferred Stock" } } }, "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubordinatedDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Subordinated Debt", "periodEndLabel": "Subordinated Debt, Ending Balance", "periodStartLabel": "Subordinated Debt, Beginning Balance", "terseLabel": "Convertible notes", "totalLabel": "Subordinated Debt, Total" } } }, "localname": "SubordinatedDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee [Line Items]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carryforwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxYear2009Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Year 2009 [Member]", "terseLabel": "Tax Year 2009" } } }, "localname": "TaxYear2009Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxYear2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Year 2022 [Member]", "terseLabel": "Tax Year 2022" } } }, "localname": "TaxYear2022Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Temporary Equity, Balance", "periodStartLabel": "Temporary Equity, Balance", "terseLabel": "Redeemable convertible preferred stock, $0.001 par value, no shares and 121,732,397 shares authorized as of December 31, 2021 and December 31, 2020, respectively; no shares issued and outstanding as of December 31, 2021 and 12,397,838 shares issued and outstanding as of December 31, 2020; liquidation value of $0 as of December 31, 2021 and $136,168 December 31, 2020, respectively", "verboseLabel": "Carrying Value" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Temporary Equity, Balance, shares", "periodStartLabel": "Temporary Equity, Balance, shares", "terseLabel": "Redeemable convertible preferred stock shares, outstanding", "verboseLabel": "Number of Shares Outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "us-gaap_ToolsDiesAndMoldsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tools, Dies and Molds [Member]", "terseLabel": "Tools and Dies" } } }, "localname": "ToolsDiesAndMoldsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowances" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfMajorIntangibleAssetsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "periodEndLabel": "Gross amount of unrecognized tax benefits as of the end of the period", "periodStartLabel": "Gross amount of unrecognized tax benefits as of the beginning of the period", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Interest or penalties accrued", "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases related to current year tax provisions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Maturity Date", "terseLabel": "Expiration Date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfCommonStockWarrantsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "verboseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "utrs_AccelmedPartnersIiLpAndNewEnterpriseAssociatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelmed Partners II LP and New Enterprise Associates.", "label": "Accelmed Partners II LP and New Enterprise Associates [Member]", "terseLabel": "Purchasers" } } }, "localname": "AccelmedPartnersIiLpAndNewEnterpriseAssociatesMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_AccelmedPartnersIiLpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelmed Partners II LP.", "label": "Accelmed Partners II LP [Member]", "terseLabel": "Accelmed" } } }, "localname": "AccelmedPartnersIiLpMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_AccrualForInventoryInTransit": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual for inventory in transit.", "label": "Accrual For Inventory In Transit", "terseLabel": "Accrual for inventory in transit" } } }, "localname": "AccrualForInventoryInTransit", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_AccruedCommissionsCurrent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails": { "order": 0.0, "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued commissions current.", "label": "Accrued Commissions Current", "terseLabel": "Accrued commissions" } } }, "localname": "AccruedCommissionsCurrent", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_AccruedContractLiability": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued contract liability.", "label": "Accrued Contract Liability", "terseLabel": "Contract liability" } } }, "localname": "AccruedContractLiability", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_AccruedDeferredRent": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued deferred rent.", "label": "Accrued Deferred Rent", "terseLabel": "Deferred rent" } } }, "localname": "AccruedDeferredRent", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_AccruedLitigation": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual for litigation.", "label": "Accrued Litigation", "terseLabel": "Accrual for litigation" } } }, "localname": "AccruedLitigation", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_AccruedSalesAndUseTaxes": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued sales and use taxes.", "label": "Accrued Sales And Use Taxes", "terseLabel": "Accrued sales and use taxes" } } }, "localname": "AccruedSalesAndUseTaxes", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantIntoCommonStockWarrantsUponInitialPublicOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments To additional paid in capital conversion of convertible preferred stock warrant into common stock warrants upon initial public offering.", "label": "Adjustments To Additional Paid In Capital Conversion of Convertible Preferred Stock Warrant into Common Stock Warrants Upon Initial Public Offering", "terseLabel": "Conversion of Series D redeemable convertible preferred stock warrants into common stock warrants upon initial public offering" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantIntoCommonStockWarrantsUponInitialPublicOffering", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "utrs_AmendmentToTwoThousandEighteenNotesAndTwoThousandNineteenNotesAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amendment to two thousand eighteen notes and two thousand nineteen notes agreements.", "label": "Amendment to Two thousand eighteen Notes and Two thousand Nineteen Notes Agreements [Member]", "terseLabel": "Amendment" } } }, "localname": "AmendmentToTwoThousandEighteenNotesAndTwoThousandNineteenNotesAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_AmendmentToTwoThousandEighteenTwoThousandNineteenAndTwoThousandTwentyNotesAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amendment to two thousand eighteen two thousand nineteen and two thousand twenty notes agreements.", "label": "Amendment To Two Thousand Eighteen Two Thousand Nineteen And Two Thousand Twenty Notes Agreements [Member]", "terseLabel": "Amended 2018 Note Agreements, 2019 Note Agreements, and 2020 Note Agreement" } } }, "localname": "AmendmentToTwoThousandEighteenTwoThousandNineteenAndTwoThousandTwentyNotesAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_ApicalInstrumentsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apical Instruments, Inc.", "label": "Apical Instruments Inc [Member]", "terseLabel": "Apical Instruments Inc" } } }, "localname": "ApicalInstrumentsIncMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_AresAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ares agreement.", "label": "Ares Agreement [Member]", "terseLabel": "Ares Agreement" } } }, "localname": "AresAgreementMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_AresTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ares term loan.", "label": "Ares term loan [Member]", "terseLabel": "Ares Term Loan" } } }, "localname": "AresTermLoanMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "domainItemType" }, "utrs_BalanceSheetComponentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Balance sheet components.", "label": "Balance Sheet Components [Abstract]" } } }, "localname": "BalanceSheetComponentsAbstract", "nsuri": "http://minervasurgical.com/20221231", "xbrltype": "stringItemType" }, "utrs_BalanceSheetComponentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent balance sheet components.", "label": "Balance Sheet Components [Line Items]", "terseLabel": "Balance Sheet Components [Line Items]" } } }, "localname": "BalanceSheetComponentsLineItems", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "utrs_BalanceSheetComponentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the balance sheet components.", "label": "Balance Sheet Components [Table]", "terseLabel": "Balance Sheet Components [Table]" } } }, "localname": "BalanceSheetComponentsTable", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "utrs_BaseRentPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Base rent payments.", "label": "Base Rent Payments", "terseLabel": "Base rent payments" } } }, "localname": "BaseRentPayments", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_CIBCAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CIBC Agreement.", "label": "C I B C Agreement [Member]", "terseLabel": "CIBC Agreement" } } }, "localname": "CIBCAgreementMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_CanadianImperialBankOfCommerceTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canadian Imperial Bank of Commerce term loan.", "label": "Canadian Imperial Bank of Commerce Term Loan [Member]", "terseLabel": "CIBC Term Loan" } } }, "localname": "CanadianImperialBankOfCommerceTermLoanMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "domainItemType" }, "utrs_ChangeInFairValueOfDerivativeLiabilities": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of derivative liabilities.", "label": "Change In Fair Value Of Derivative Liabilities", "terseLabel": "Change in fair value of derivative liabilities" } } }, "localname": "ChangeInFairValueOfDerivativeLiabilities", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "utrs_ClassOfWarrantOrRightClassification": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right, Classification", "label": "Classification" } } }, "localname": "ClassOfWarrantOrRightClassification", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfCommonStockWarrantsDetails" ], "xbrltype": "stringItemType" }, "utrs_ClassOfWarrantOrRightToPurchaseOfCommonStockIssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right to purchase of common stock issuance date.", "label": "Issuance date", "terseLabel": "Issuance Date" } } }, "localname": "ClassOfWarrantOrRightToPurchaseOfCommonStockIssuanceDate", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfCommonStockWarrantsDetails" ], "xbrltype": "dateItemType" }, "utrs_CommonStockAvailableForEmployeeStockPurchasePlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock available for employee stock purchase plan.", "label": "Common Stock Available For Employee Stock Purchase Plan", "terseLabel": "Common stock available for ESPP" } } }, "localname": "CommonStockAvailableForEmployeeStockPurchasePlan", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "utrs_CommonStockOptionsIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock options issued and outstanding.", "label": "Common Stock Options Issued And Outstanding", "terseLabel": "Common stock options issued and outstanding" } } }, "localname": "CommonStockOptionsIssuedAndOutstanding", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "utrs_CommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrants.", "label": "Common Stock Warrants [Member]", "terseLabel": "Common Stock Warrants" } } }, "localname": "CommonStockWarrantsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "domainItemType" }, "utrs_CommonStockWarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrants.", "label": "Common Stock Warrants [Text Block]", "terseLabel": "Common Stock Warrants" } } }, "localname": "CommonStockWarrantsTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrants" ], "xbrltype": "textBlockItemType" }, "utrs_ComputerAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer and Software.", "label": "Computer And Software [Member]", "terseLabel": "Computer and Software" } } }, "localname": "ComputerAndSoftwareMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "utrs_ConcentrationOfSuppliers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for concentration of suppliers.", "label": "Concentration Of Suppliers", "terseLabel": "Concentration of Suppliers" } } }, "localname": "ConcentrationOfSuppliers", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "utrs_ContingentConsiderationLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent consideration liability member.", "label": "Contingent Consideration Liability [Member]", "terseLabel": "Contingent Consideration Liability" } } }, "localname": "ContingentConsiderationLiabilityMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "utrs_DebtInstrumentAccruedInterest": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails": { "order": 2.0, "parentTag": "utrs_TermLoanIncludingAccruedInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt instrument accrued interest.", "label": "Debt Instrument Accrued Interest", "terseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentAccruedInterest", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DebtInstrumentAdvanceClosingOfTrancheAgreementDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument Advance, Closing of Tranche Agreement Date.", "label": "Debt Instrument Advance Closing Of Tranche Agreement Date", "terseLabel": "Debt instrument advance, closing of tranche agreement date" } } }, "localname": "DebtInstrumentAdvanceClosingOfTrancheAgreementDate", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "utrs_DebtInstrumentAdvanceClosingOfTrancheAgreementPeriodPriorToClosing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument Advance, Closing of Tranche Agreement Period Prior to Closing.", "label": "Debt Instrument Advance Closing Of Tranche Agreement Period Prior To Closing", "terseLabel": "Debt instrument advance, closing of tranche agreement period prior to closing" } } }, "localname": "DebtInstrumentAdvanceClosingOfTrancheAgreementPeriodPriorToClosing", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "utrs_DebtInstrumentAdvancedAtClosingOfAgreementTrancheA": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Advanced at Closing of Agreement Tranche A.", "label": "Debt Instrument Advanced At Closing Of Agreement Tranche A", "terseLabel": "Debt instrument advanced at closing of agreement tranche A" } } }, "localname": "DebtInstrumentAdvancedAtClosingOfAgreementTrancheA", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DebtInstrumentAdvancedAtClosingOfAgreementTrancheB": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Advanced at Closing of Agreement Tranche B.", "label": "Debt Instrument Advanced At Closing Of Agreement Tranche B", "terseLabel": "Debt instrument advanced at closing of agreement tranche B" } } }, "localname": "DebtInstrumentAdvancedAtClosingOfAgreementTrancheB", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DebtInstrumentAdvancedConditionedUponAchievingMinimumAmountInNetRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Advanced Conditioned Upon Achieving Minimum Amount in Net Revenues.", "label": "Debt Instrument Advanced Conditioned Upon Achieving Minimum Amount In Net Revenues", "terseLabel": "Minimum amount conditioned upon achieving in net revenues" } } }, "localname": "DebtInstrumentAdvancedConditionedUponAchievingMinimumAmountInNetRevenues", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DebtInstrumentExtendedMaturityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument extended maturity period.", "label": "Debt Instrument Extended Maturity Period", "terseLabel": "Debt instrument extended maturity period" } } }, "localname": "DebtInstrumentExtendedMaturityPeriod", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "gYearMonthItemType" }, "utrs_DebtInstrumentFixedExitFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument fixed exit fee percentage.", "label": "Debt Instrument Fixed Exit Fee Percentage", "terseLabel": "Debt instrument fixed exit fee percentage" } } }, "localname": "DebtInstrumentFixedExitFeePercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_DebtInstrumentInterestForgiven": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt instrument interest forgiven.", "label": "Debt Instrument Interest Forgiven", "terseLabel": "Debt instrument interest forgiven" } } }, "localname": "DebtInstrumentInterestForgiven", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DebtInstrumentInterestRateIncreaseUponOccuranceAndContinuanceOfEventOfDefault": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument interest rate increase upon occurance and continuance of event of default.", "label": "Debt Instrument Interest Rate Increase Upon Occurance and Continuance of Event of Default", "terseLabel": "Debt instrument interest rate increase upon occurance and continuance of event of default." } } }, "localname": "DebtInstrumentInterestRateIncreaseUponOccuranceAndContinuanceOfEventOfDefault", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_DebtInstrumentsAccruedInterestRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instruments Accrued Interest Rate Percentage.", "label": "Debt Instruments Accrued Interest Rate Percentage", "terseLabel": "Debt instruments accrued interest rate percentage" } } }, "localname": "DebtInstrumentsAccruedInterestRatePercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_DeferredPaymentObligationsAdditionalAmountToBeDrawnRetained": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred payment obligations additional amount to be drawn retained.", "label": "Deferred Payment Obligations Additional Amount to be Drawn Retained", "terseLabel": "Deferred payment obligations additional amount to be drawn retained" } } }, "localname": "DeferredPaymentObligationsAdditionalAmountToBeDrawnRetained", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DeferredTaxAssetsDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets depreciation and amortization.", "label": "Deferred Tax Assets Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxAssetsDepreciationAndAmortization", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DeferredTaxAssetsLeaseLiability": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets, lease liability.", "label": "Deferred Tax Assets Lease Liability", "terseLabel": "Lease liability" } } }, "localname": "DeferredTaxAssetsLeaseLiability", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DeferredTaxLiabilitiesDebtDiscount": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities, debt discount", "label": "Deferred Tax Liabilities, Debt Discount", "negatedLabel": "Debt discount" } } }, "localname": "DeferredTaxLiabilitiesDebtDiscount", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxEffectsOfTemporaryDifferencesAndCarryforwardsOfDeferredTaxDeferredTaxAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "utrs_DevelopedTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Developed technology.", "label": "Developed Technology [Member]", "terseLabel": "Developed Technology" } } }, "localname": "DevelopedTechnologyMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfIntangibleAssetNetDetails" ], "xbrltype": "domainItemType" }, "utrs_EffectiveIncomeTaxRateReconciliationConvertibleDebtEmbeddedDerivative": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation convertible debt embedded derivative.", "label": "Effective Income Tax Rate Reconciliation Convertible Debt Embedded Derivative", "terseLabel": "Convertibel debt embedded derivative" } } }, "localname": "EffectiveIncomeTaxRateReconciliationConvertibleDebtEmbeddedDerivative", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "utrs_EffectiveIncomeTaxRateReconciliationGainLossOnDebtExtinguishment": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation gain (loss) on debt extinguishment", "label": "Effective Income Tax Rate Reconciliation Gain (Loss) on Debt Extinguishment", "terseLabel": "Gain on debt extinguishment of debt" } } }, "localname": "EffectiveIncomeTaxRateReconciliationGainLossOnDebtExtinguishment", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "utrs_EquipmentUnderCustomerUsageAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment under customer usage agreements.", "label": "Equipment Under Customer Usage Agreements [Member]", "terseLabel": "Equipment Under Customer Usage Agreements" } } }, "localname": "EquipmentUnderCustomerUsageAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "utrs_ExpectedDerecognizedDeferredRent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expected derecognized deferred rent.", "label": "Expected Derecognized Deferred Rent", "terseLabel": "Expected derecognized deferred rent" } } }, "localname": "ExpectedDerecognizedDeferredRent", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_ExpectedOperatingLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expected operating lease liability.", "label": "Expected Operating Lease Liability", "terseLabel": "Expected operating lease liability" } } }, "localname": "ExpectedOperatingLeaseLiability", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_ExpectedOperatingLeaseRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expected operating lease right-of-use assets.", "label": "Expected Operating Lease Right of Use Assets", "terseLabel": "Expected operating lease right of use assets" } } }, "localname": "ExpectedOperatingLeaseRightOfUseAssets", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoCommonStockWarrant": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability conversion into common stock warrant.", "label": "Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Liability Conversion into Common Stock Warrant", "terseLabel": "Conversion into common stock warrant" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoCommonStockWarrant", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "utrs_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPaymentOfDevelopmentMilestone": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability payment of development milestone.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Payment of Development Milestone", "terseLabel": "Payment of Development Milestone" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPaymentOfDevelopmentMilestone", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "utrs_FiniteLivedFutureAmortizationOfIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite lived future amortization of intangible assets net.", "label": "Finite Lived Future Amortization of Intangible Assets Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedFutureAmortizationOfIntangibleAssetsNet", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfFutureAmortizationExpenseOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_GainLossOnDebtModification": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on debt modification.", "label": "Gain (Loss) on debt modification", "terseLabel": "Gain (loss) on debt modification" } } }, "localname": "GainLossOnDebtModification", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_GainLossOnExtinguishmentOfPayrollProtectionProgramLoan": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (Loss) on Extinguishment of Payroll Protection Program Loan.", "label": "Gain Loss On Extinguishment Of Payroll Protection Program Loan", "terseLabel": "Gain on extinguishment of PPP loan" } } }, "localname": "GainLossOnExtinguishmentOfPayrollProtectionProgramLoan", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "utrs_GainLossOnForgivenessOfLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on forgiveness of loan.", "label": "Gain (Loss) On Forgiveness Of Loan", "terseLabel": "Gain on forgiveness of debt" } } }, "localname": "GainLossOnForgivenessOfLoan", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_GenesysHTAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Genesys HTA.", "label": "Genesys H T A [Member]", "terseLabel": "Genesys HTA" } } }, "localname": "GenesysHTAMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "utrs_GreaterThanChangeInEquityOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greater than change in equity ownership percentage", "label": "Greater Than Change In Equity Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "GreaterThanChangeInEquityOwnershipPercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_GrossProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds from issuance of private placement.", "label": "Gross Proceeds From Issuance Of Private Placement", "terseLabel": "Gross proceeds of private placement" } } }, "localname": "GrossProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_HologicIncAndCytycSurgicalProductsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hologic, Inc. and Cytyc Surgical Products, LLC.", "label": "Hologic, Inc. and Cytyc Surgical Products, LLC Member", "terseLabel": "Hologic, Inc. and Cytyc Surgical Products, LLC" } } }, "localname": "HologicIncAndCytycSurgicalProductsLlcMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_IncomeTaxRemainOpenYearForExamination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income tax remain open year for examination.", "label": "Income Tax Remain Open Year for Examination", "terseLabel": "Income tax remain open year for examination" } } }, "localname": "IncomeTaxRemainOpenYearForExamination", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "utrs_IncomeTaxesRollingYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income taxes rolling year", "label": "Income Taxes Rolling Year", "terseLabel": "Income taxes rolling year" } } }, "localname": "IncomeTaxesRollingYear", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "utrs_IncrementalAnnualRentalPaymentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incremental annual rental payment percentage.", "label": "Incremental Annual Rental Payment Percentage", "terseLabel": "Incremental annual rental payment percentage" } } }, "localname": "IncrementalAnnualRentalPaymentPercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_InventoryComponentMaterials": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory component materials.", "label": "Inventory Component Materials", "terseLabel": "Component materials" } } }, "localname": "InventoryComponentMaterials", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "utrs_IssuanceOfCommonStockUponEarlyExerciseOfStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon early exercise of stock options.", "label": "Issuance of Common Stock Upon Early Exercise of Stock Options", "terseLabel": "Issuance of common stock upon early exercise of stock options, shares" } } }, "localname": "IssuanceOfCommonStockUponEarlyExerciseOfStockOptions", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "utrs_JumpstartOurBusinessStartupsActAccountingElectionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jumpstart Our Business Startups Act Accounting Election [Policy Text Block]", "label": "Jumpstart Our Business Startups Act Accounting Election [Policy Text Block]", "terseLabel": "JOBS Act Accounting Election" } } }, "localname": "JumpstartOurBusinessStartupsActAccountingElectionPolicyTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "utrs_LeaseExpiresOnMayTwentyTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease expires on May twenty twenty three.", "label": "Lease Expires on May Twenty Twenty Three [Member]", "terseLabel": "Lease Expires on May 31, 2023" } } }, "localname": "LeaseExpiresOnMayTwentyTwentyThreeMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "utrs_LesseeOperatingLeaseLeaseNotYetCommencedExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease lease not yet commenced start date.", "label": "Lessee Operating Lease Lease Not Yet Commenced Expiration Date", "terseLabel": "Lease expiration date" } } }, "localname": "LesseeOperatingLeaseLeaseNotYetCommencedExpirationDate", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "utrs_LesseeOperatingLeaseLeaseNotYetCommencedStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease lease not yet commenced start date.", "label": "Lessee Operating Lease Lease Not Yet Commenced Start Date", "terseLabel": "Lease commencement date" } } }, "localname": "LesseeOperatingLeaseLeaseNotYetCommencedStartDate", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "utrs_LongTermDebtIncludingInterestPayments": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": 0.0, "parentTag": "utrs_TermLoanIncludingAccruedInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term debt including interest payments.", "label": "Long Term Debt Including Interest Payments", "totalLabel": "Total" } } }, "localname": "LongTermDebtIncludingInterestPayments", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": 3.0, "parentTag": "utrs_LongTermDebtIncludingInterestPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal including interest in next twelve months.", "label": "Long Term Debt Maturities Repayments of Principal Including Interest in Next Twelve Months", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInNextTwelveMonths", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInYearFour": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": 1.0, "parentTag": "utrs_LongTermDebtIncludingInterestPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal including interest in year four.", "label": "Long Term Debt Maturities Repayments of Principal Including Interest in Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInYearFour", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInYearThree": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": 2.0, "parentTag": "utrs_LongTermDebtIncludingInterestPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal including interest in year three.", "label": "Long Term Debt Maturities Repayments of Principal Including Interest in Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInYearThree", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInYearTwo": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": 0.0, "parentTag": "utrs_LongTermDebtIncludingInterestPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal including interest in year two.", "label": "Long Term Debt Maturities Repayments of Principal Including Interest in Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalIncludingInterestInYearTwo", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_MaximumAmountSuccessFeeRequiredToPayUnderAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum amount success fee required to pay under agreement.", "label": "Maximum Amount Success Fee Required To Pay Under Agreement", "terseLabel": "Maximum amount success fee required to pay under agreement" } } }, "localname": "MaximumAmountSuccessFeeRequiredToPayUnderAgreement", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_MaximumPercentageOfEligibleCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of eligible compensation.", "label": "Maximum Percentage of Eligible Compensation", "terseLabel": "Maximum percentage of eligible compensation" } } }, "localname": "MaximumPercentageOfEligibleCompensation", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "utrs_MinervaESMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minerva ES.", "label": "Minerva E S [Member]", "terseLabel": "Minerva ES" } } }, "localname": "MinervaESMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "utrs_NonCancellableLease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cancellable lease.", "label": "Non-cancellable lease" } } }, "localname": "NonCancellableLease", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_NumberOfCustomerAccountedForAccountsReceivableOrRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of customer accounted for accounts receivable or revenue.", "label": "Number of Customer Accounted for Accounts Receivable or Revenue", "terseLabel": "Number of customer accounted for accounts receivable or revenue" } } }, "localname": "NumberOfCustomerAccountedForAccountsReceivableOrRevenue", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "utrs_OfferingPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering price per share.", "label": "Offering Price Per Share", "terseLabel": "Offering price per share", "verboseLabel": "Public offering price per share" } } }, "localname": "OfferingPricePerShare", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "utrs_OperatingLossCarryforwardsExpirationBeginningYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards expiration beginning year.", "label": "Operating Loss Carryforwards Expiration Beginning Year", "terseLabel": "Net operating loss carry forwards expire beginning year" } } }, "localname": "OperatingLossCarryforwardsExpirationBeginningYear", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "utrs_OperatingNonCancellableLeaseTerminateDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating non cancellable lease terminate date.", "label": "Operating Non Cancellable Lease Terminate Date", "terseLabel": "Operating non-cancellable lease terminate date" } } }, "localname": "OperatingNonCancellableLeaseTerminateDate", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "utrs_OtherLeaseInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other lease information.", "label": "Other Lease Information [Abstract]", "terseLabel": "Other Information" } } }, "localname": "OtherLeaseInformationAbstract", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails" ], "xbrltype": "stringItemType" }, "utrs_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other member.", "label": "Other [Member]", "terseLabel": "Other" } } }, "localname": "OtherMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "utrs_OwnershipPercentageIncreased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership percentage increased", "label": "Ownership Percentage Increased", "terseLabel": "Ownership percentage increased" } } }, "localname": "OwnershipPercentageIncreased", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PaycheckProtectionProgramLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program loan.", "label": "Paycheck Protection Program Loan [Member]", "terseLabel": "Paycheck Protection Program Loan" } } }, "localname": "PaycheckProtectionProgramLoanMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtPaycheckProtectionProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_PaymentOfSuccessFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of success fee.", "label": "Payment Of Success Fee", "negatedLabel": "Payment of success fee", "terseLabel": "Payment of success fee" } } }, "localname": "PaymentOfSuccessFee", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_Payments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments.", "label": "Payments", "terseLabel": "Payment" } } }, "localname": "Payments", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "utrs_PercentageOfCommonStockOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock owned.", "label": "Percentage Of Common Stock Owned", "terseLabel": "Percentage of common stock owned" } } }, "localname": "PercentageOfCommonStockOwned", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfExercisePriceDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of exercise price discount rate.", "label": "Percentage Of Exercise Price Discount", "terseLabel": "Percentage of exercise price discount rate" } } }, "localname": "PercentageOfExercisePriceDiscount", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfInterestOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of interest owned.", "label": "Percentage of Interest Owned", "terseLabel": "Percentage of interest owned" } } }, "localname": "PercentageOfInterestOwned", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfMinimumStockHeldByEmployeeToDetermineExercisePriceOfOptionsOnDateOfGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of minimum stock held by employee to determine exercise price of options on date of grant.", "label": "Percentage Of Minimum Stock Held By Employee To Determine Exercise Price Of Options On Date Of Grant", "terseLabel": "Estimated fair value shares date of grant" } } }, "localname": "PercentageOfMinimumStockHeldByEmployeeToDetermineExercisePriceOfOptionsOnDateOfGrant", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Revenue From Contract With Customer Excluding Assessed Tax.", "label": "Percentage Of Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Disaggregation of revenue, percentage" } } }, "localname": "PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfRevenueOnSaleOfExtendedWarrantiesOnCapitalEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of revenue on sale of extended warranties on capital equipment.", "label": "Percentage of Revenue on Sale of Extended Warranties on Capital Equipment", "terseLabel": "Percentage of revenue on sale of extended warranties on capital equipment" } } }, "localname": "PercentageOfRevenueOnSaleOfExtendedWarrantiesOnCapitalEquipment", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfRevenueSubjectToPointInTimeRecognition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of revenue subject to point-in-time recognition.", "label": "Percentage Of Revenue Subject To Point In Time Recognition", "terseLabel": "Percentage of revenue subject to point-in-time recognition" } } }, "localname": "PercentageOfRevenueSubjectToPointInTimeRecognition", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of total revenue derived from sale of single-use (disposable) products.", "label": "Percentage of Total Revenue Derived from Sale of Single Use Disposable Products", "terseLabel": "Percentage of total revenue derived from sale of single-use (disposable) products" } } }, "localname": "PercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PremiumPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Premium percentage.", "label": "Premium Percentage", "terseLabel": "Premium percentage" } } }, "localname": "PremiumPercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PrepaymentPremiumEarnedPercentageOnPrincipal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayment premium earned percentage on principal.", "label": "Prepayment Premium Earned Percentage On Principal", "terseLabel": "Prepayment premium earned percentage on principal" } } }, "localname": "PrepaymentPremiumEarnedPercentageOnPrincipal", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PrepaymentPremiumPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayment premium percentage.", "label": "Prepayment Premium Percentage", "terseLabel": "Prepayment premium percentage" } } }, "localname": "PrepaymentPremiumPercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_PrivatePlacementAgentFeesAndOfferingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Private placement agent fees and offering expenses", "label": "Private Placement Agent Fees And Offering Expenses", "terseLabel": "Private placement agent fees and offering expenses" } } }, "localname": "PrivatePlacementAgentFeesAndOfferingExpenses", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_ProceedsFromIssuanceInitialPublicOfferingGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance initial public offering gross.", "label": "Proceeds From Issuance Initial Public Offering Gross", "terseLabel": "Aggregate gross proceeds", "verboseLabel": "Gross proceeds from offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOfferingGross", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_RedeemableConvertiblePreferredStockWarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock warrant liability.", "label": "Redeemable Convertible Preferred Stock Warrant Liability [Member]", "terseLabel": "Redeemable Convertible Preferred Stock Warrant Liability" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueSummaryOfRedeemableConvertiblePreferredStockWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "utrs_RedeemableConvertiblePreferredStockWarrantsAndCommonStockWarrantsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable Convertible Preferred Stock Warrants and Common Stock Warrants [Policy Text Block]", "label": "Redeemable Convertible Preferred Stock Warrants and Common Stock Warrants [Policy Text Block]", "terseLabel": "Redeemable Convertible Preferred Stock Warrants and Common Stock Warrants" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantsAndCommonStockWarrantsPolicyTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "utrs_RelatedPartyTransactionFeesChargedTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction Fees Charged Transactions With Related Party.", "label": "Related Party Transaction Fees Charged Transactions With Related Party", "terseLabel": "Fees charged" } } }, "localname": "RelatedPartyTransactionFeesChargedTransactionsWithRelatedParty", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_RepaymentLoanPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Repayment loan percentage.", "label": "Repayment Loan Percentage", "terseLabel": "Repayment loan percentage" } } }, "localname": "RepaymentLoanPercentage", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtAresTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "utrs_RepurchaseOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Repurchase of common stock.", "label": "Repurchase Of Common Stock", "terseLabel": "Repurchase of common stock" } } }, "localname": "RepurchaseOfCommonStock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "sharesItemType" }, "utrs_RestrictedCashMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted cash.", "label": "Restricted Cash [Member]", "terseLabel": "Restricted Cash" } } }, "localname": "RestrictedCashMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_RestrictedStockUnitsIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock units issued and outstanding.", "label": "Restricted Stock Units Issued And Outstanding", "terseLabel": "Restricted stock units issued and outstanding" } } }, "localname": "RestrictedStockUnitsIssuedAndOutstanding", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "utrs_ScheduleOfAccruedCompensationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued compensation.", "label": "Schedule Of Accrued Compensation Table [Text Block]", "terseLabel": "Schedule of Accrued Compensation" } } }, "localname": "ScheduleOfAccruedCompensationTableTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "utrs_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of prepaid expenses and other current assets.", "label": "Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block]", "terseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "utrs_ScheduleOfSharesReservedForFutureIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of shares reserved for future issuance.", "label": "Schedule Of Shares Reserved For Future Issuance Table [Text Block]", "terseLabel": "Schedule of Reserved Shares for Future Issuance" } } }, "localname": "ScheduleOfSharesReservedForFutureIssuanceTableTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "utrs_SecondLienLoanAndSecurityAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Lien Loan and Security Agreements.", "label": "Second Lien Loan And Security Agreements [Member]", "terseLabel": "Second Lien Loan and Security Agreements" } } }, "localname": "SecondLienLoanAndSecurityAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_SeriesDRedeemableConvertiblePreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D redeemable convertible preferred stock warrants.", "label": "Series D Redeemable Convertible Preferred Stock Warrants [Member]", "terseLabel": "Series D Redeemable Convertible Preferred Stock Warrants" } } }, "localname": "SeriesDRedeemableConvertiblePreferredStockWarrantsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfFairValueOfStockOptionsEstimatedUsingWeightedaverageAssumptionsDetails", "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsTables" ], "xbrltype": "domainItemType" }, "utrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award equity instruments other than options, released, weighted average grant date fair value.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award Equity Instruments Other than Options, released, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Unvested, Released" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "utrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award maximum vesting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Vesting Period", "terseLabel": "Share-based Compensation arrangement by share-based payment award, award vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumVestingPeriod", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "durationItemType" }, "utrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentOfEstimatedFairMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options exercise price percent of estimated fair market value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Percent Of Estimated Fair Market Value", "terseLabel": "Exercise price, percent of estimated fair market value of shares on date of grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentOfEstimatedFairMarketValue", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "utrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentOfEstimatedFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options exercise price percent of estimated fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Percent Of Estimated Fair Value", "terseLabel": "Exercise price, percent of estimated fair value of shares on date of grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentOfEstimatedFairValue", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "percentItemType" }, "utrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchaseOfGrantDateShareValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award purchase of grant date share value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Purchase of Grant Date Share Value", "terseLabel": "Purchase of common stock grant date share value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchaseOfGrantDateShareValue", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "monetaryItemType" }, "utrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardRatablyThereafterVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award ratably thereafter vesting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Ratably Thereafter Vesting Period", "terseLabel": "Share based compensation arrangement by share based payment award ratably thereafter vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRatablyThereafterVestingPeriod", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "durationItemType" }, "utrs_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAggregateExercisePricesOfEarlyExercisedShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangements by share based payment award options aggregate exercise prices of early exercised shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Aggregate Exercise Prices Of Early Exercised Shares", "terseLabel": "Aggregate exercise prices of early exercised shares" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAggregateExercisePricesOfEarlyExercisedShares", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "monetaryItemType" }, "utrs_SharePurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Purchase Agreement.", "label": "Share Purchase Agreement [Member]", "terseLabel": "Purchase Agreement" } } }, "localname": "SharePurchaseAgreementMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_SharebasedcompensationarrangementbyshareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebasedcompensationarrangementbyshare based payment award equity instruments other than options released in period.", "label": "ShareBasedCompensationArrangementByShare Based Payment Award Equity Instruments Other Than Options Released in Period", "negatedLabel": "Number of Shares Underlying Outstanding Restricted Stock, Released" } } }, "localname": "SharebasedcompensationarrangementbyshareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "utrs_StockIssuedDuringPeriodSharesConvertibleNotesInToCommonStockUponInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares convertible notes in to common stock upon initial public offering.", "label": "Stock Issued During Period Shares Convertible Notes In To Common Stock Upon Initial Public Offering", "terseLabel": "Conversion of 2018, 2019 and 2020 Notes into common stock upon initial public offering, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConvertibleNotesInToCommonStockUponInitialPublicOffering", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "utrs_StockIssuedDuringPeriodValueConvertibleNotesInToCommonStockUponInitialPublicOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value convertible notes in to common stock upon initial public offering.", "label": "Stock Issued During Period Value Convertible Notes In To Common Stock Upon Initial Public Offering", "terseLabel": "Conversion of 2018, 2019 and 2020 Notes into common stock upon initial public offering" } } }, "localname": "StockIssuedDuringPeriodValueConvertibleNotesInToCommonStockUponInitialPublicOffering", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "utrs_StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period, value, vesting of early exercised stock options.", "label": "Stock Issued During Period Value Vesting Of Early Exercised Stock Options", "terseLabel": "Vesting of early exercised stock options" } } }, "localname": "StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "utrs_SuccessFeeDerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Success fee derivative liability.", "label": "Success Fee Derivative Liability", "terseLabel": "Success fee derivative liability" } } }, "localname": "SuccessFeeDerivativeLiability", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "utrs_SummaryOfUsefulLivesOfIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of useful lives of intangible assets.", "label": "Summary of Useful Lives of Intangible Assets [Table Text Block]", "terseLabel": "Summary of Useful Lives of Major Intangible Assets" } } }, "localname": "SummaryOfUsefulLivesOfIntangibleAssetsTableTextBlock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "utrs_SymphionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Symphion member.", "label": "Symphion [Member]", "terseLabel": "Symphion" } } }, "localname": "SymphionMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureRevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "utrs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity stock issued during period shares conversion of convertible securities.", "label": "Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities", "terseLabel": "Conversion of Series D redeemable convertible preferred stock into common stock upon initial public offering, shares" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "sharesItemType" }, "utrs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Temporary equity stock issued during period value conversion of convertible securities.", "label": "Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities", "terseLabel": "Conversion of Series D redeemable convertible preferred stock into common stock upon initial public offering" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquity1" ], "xbrltype": "monetaryItemType" }, "utrs_TermLoanIncludingAccruedInterest": { "auth_ref": [], "calculation": { "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Term loan including accrued interest.", "label": "Term Loan Including Accrued Interest", "totalLabel": "Term loan" } } }, "localname": "TermLoanIncludingAccruedInterest", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureDebtCibcTermLoanScheduleOfDebtDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtScheduleOfContractualMaturitiesOfFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "utrs_TwoThousandAndEightStockPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and eight stock plan.", "label": "Two Thousand And Eight Stock Plan [Member]", "terseLabel": "2008 Stock Plan" } } }, "localname": "TwoThousandAndEightStockPlanMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandEighteenSecondLienLoanAndSecurityAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen second lien loan and security agreements.", "label": "Two Thousand Eighteen Second Lien Loan and Security Agreements [Member]", "terseLabel": "2018 Note Agreements" } } }, "localname": "TwoThousandEighteenSecondLienLoanAndSecurityAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandEighteenTwoThousandNineteenAndTwoThousandTwentyNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Eighteen Two Thousand Nineteen and Two Thousand Twenty Notes.", "label": "Two Thousand Eighteen Two Thousand Nineteen and Two Thousand Twenty Notes [Member]", "terseLabel": "Convertible Notes", "verboseLabel": "2018, 2019 and 2020 Notes" } } }, "localname": "TwoThousandEighteenTwoThousandNineteenAndTwoThousandTwentyNotesMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails", "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandNineteenSecondLienLoanAndSecurityAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand nineteen second lien loan and security agreements.", "label": "Two thousand Nineteen second lien loan and security agreements [Member]", "terseLabel": "2019 Note Agreements" } } }, "localname": "TwoThousandNineteenSecondLienLoanAndSecurityAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandTwentyNoteAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Note Agreements.", "label": "Two Thousand Twenty Note Agreements [Member]", "terseLabel": "2020 Note Agreements" } } }, "localname": "TwoThousandTwentyNoteAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandTwentyOneEmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one employee stock purchase plan.", "label": "Two Thousand Twenty One Employee Stock Purchase Plan [Member]", "terseLabel": "ESPP" } } }, "localname": "TwoThousandTwentyOneEmployeeStockPurchasePlanMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one equity incentive plan.", "label": "Two Thousand Twenty One Equity Incentive Plan [Member]", "terseLabel": "2021 Plan" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails1" ], "xbrltype": "domainItemType" }, "utrs_TwoThousandTwentySecondLienLoanAndSecurityAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty second lien loan and security agreements.", "label": "Two thousand twenty second lien loan and security agreements [Member]", "terseLabel": "2020 Note Agreement" } } }, "localname": "TwoThousandTwentySecondLienLoanAndSecurityAgreementsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/Role_DisclosureDebtConvertibleNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_UnvestedEarlyExercisedCommonStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unvested early exercised common stock options.", "label": "Unvested Early Exercised Common Stock Options [Member]", "terseLabel": "Unvested Early Exercised Common Stock Options" } } }, "localname": "UnvestedEarlyExercisedCommonStockOptionsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "domainItemType" }, "utrs_UnvestedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unvested restricted stock units.", "label": "Unvested Restricted Stock Units[Member]", "terseLabel": "Unvested Restricted Stock Units" } } }, "localname": "UnvestedRestrictedStockUnitsMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesOutstandingInCommonStockEquivalentExcludedFromCom" ], "xbrltype": "domainItemType" }, "utrs_VolumeWeightedAveragePriceTrailingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume weighted average price trailing period.", "label": "Volume Weighted Average Price Trailing Period", "terseLabel": "Volume weighted average price trailing period" } } }, "localname": "VolumeWeightedAveragePriceTrailingPeriod", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "utrs_WarrantExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expiration period.", "label": "Warrant Expiration Period", "terseLabel": "Warrant expiration period" } } }, "localname": "WarrantExpirationPeriod", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "utrs_WarrantsToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants to purchase common stock.", "label": "Warrants To Purchase Common Stock", "terseLabel": "Warrants to purchase common stock" } } }, "localname": "WarrantsToPurchaseCommonStock", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfReservedSharesForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "utrs_WarrantyServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warranty service.", "label": "Warranty Service [Member]", "terseLabel": "Warranty" } } }, "localname": "WarrantyServiceMember", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "utrs_WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted-average shares used in computing net loss per share basic and diluted", "label": "Weighted-average Shares Used in Computing Net Loss Per Share Basic and Diluted", "terseLabel": "Weighted-average common shares used in computing net loss per share, basic and diluted", "verboseLabel": "Weighted-average common stock outstanding" } } }, "localname": "WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted", "nsuri": "http://minervasurgical.com/20221231", "presentation": [ "http://minervasurgical.com/20221231/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://minervasurgical.com/20221231/taxonomy/role/StatementStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 2 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" }